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Delayed-type hypersensitivity  (DTH) 1 is a  T  cell-mediated  reaction resulting in a 
mononuclear  cell-rich  inflammation  and  swelling  that  peak  24-48  h  after  local 
antigenic  challenge.  In spite  of the  extensive  use  of DTH  to dissect  regulatory  (1), 
genetic  (2),  and  molecular  (3)  aspects of in vivo T  cell  responses,  little  is known of 
factors that regulate the persistence of these reactions. It is thought that granulomata, 
such as those seen in tuberculosis and schistosomiasis, provide an example of prolonged 
DTH  (4, 5) resulting from either the persistence of antigen  (6)  or from the absence of 
regulatory  factors  that  promote  the  decay of DTH  (7).  An experimental  model  of 
prolonged T  cell-dependent  inflammation,  in which a  nonpersistent  form of antigen 
is used, would allow an easier dissection of these regulatory factors and perhaps lead 
to maneuvers  that  abort  some inflammatory responses.  In this  paper  we show that 
administration  of pertussigen,  a  purified protein  from Bordetella pertussis  (8), leads to 
intense  and  persistent  DTH  lesions  in  mice  that  are  sensitized  either  actively  or 
passively to protein antigens. 
Materials  and Methods 
Mice.  8-10-wk old female mice of the BALB/cAn.BradleyWEHI strain were used through- 
out. All mice used were bred in specific pathogen-free conditions at The Walter and Eliza Hall 
Institute, and transferred to conventional mouse rooms before experiments. 
Pertussigen.  The crystalline preparation used in this work was made from supernatant fluids 
of 5-d old cultures of Bordetella pertussis by a modification of the method described by Cowell et 
al.  (9). The  preparation  was  extensively  dialyzed  against  cold  distilled  water  and  then 
lyophilized. This dried material was kept in a desiccator at 4°C until needed. Solutions of dried 
pertussigen were made by weighing the desired amount and dissolving it in alanine formic acid 
buffer, pH 3.5  (6.78  g DL-a-alanine plus 0.7  g formic acid in  1 liter H~O),  and immediately 
thereafter diluting it with an equal volume of 0.05 M Tris buffer, pH 8, containing 1 M sodium 
chloride. The solution, which usually contained 200 #g/ml,  was stored at  -15°C  for a  few 
months without losing its activity. For inoculation of mice, this stock solution was diluted in 
phosphate-buffered saline (PBS)  to contain 2/~g/ml, and injected intravenously. 
The BALB/c mice used in the present work responded to the intravenous administration of 
pertussigen  with  an  increased  susceptibility  to  a  mixture  of 200  #g  histamine  and  50 #g 
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serotonin (SDs0 -- 13 ng) and with a marked leukocytosis (over threefold the normal leukocyte 
count when 140 ng of  pertussigen were given). These two actions are characteristic of pertussigen 
(10). In some experiments pertussigen was inactivated by placement in a boiling water bath for 
20 min (10). 
Endotoxin.  The sample used was made from B. pertussis cells by the phenol-water method of 
Westphal et al. (11). 
Immunization.  Mice were immunized with an emulsion made of equal volumes of an antigen 
solution (1 mg/ml) and complete Freund's adjuvant (CFA) (Difco Laboratories, Michigan). A 
total volume of 0.1 ml per mouse was administered subcutaneously into the hind foot pads and 
abdomen. The antigens used were keyhole limpet hemocyanin (KLH)  (Calbiochem-Behring, 
La Jolla, CA) and 5X recrystallized egg albumin (EA) (ICN Pharmaceuticals, Inc., OH). In 
some experiments, 2 d  before immunization, mice were injected with  100-150  mg/kg cyclo- 
phosphamide (CY)  (Endoxan-Asta; Bristol Laboratories, Australia) subcutaneously into the 
nape of the neck. 
Challenge.  6  d  after immunization, the left pinnae of mice were subcutaneously injected 
with 10 #1 of  solution containing 1 mg/ml of antigen. The difference in ear thickness (increment) 
between the left and right pinnae was determined by measuring both ears with a spring-loaded 
micrometer (Mitutoyo Mfg. Co., Tokyo, Japan). 
Nonspecific Irritants.  Mice were injected in the left hind footpad with either 20 #1 mineral 
turpentine (neat) or 50 #1 of an emulsion of equal volumes of incomplete Freund's adjuvant 
(IFA)  (Difco  Laboratories)  and  isotonic sodium  chloride.  The  increment  in  hind  footpad 
thickness was determined in the same way as the ear increment. 
Cell Transfer.  To increase passive transfer of DTH  (12) donor mice were treated with  150 
mg/kg CY 2 d before immunization with KLH in CFA. 5 d later, mice were killed by cervical 
dislocation and the popliteal, inguinal, and para-aortie lymph nodes were excised. A single-cell 
suspension was prepared by teasing the lymph nodes through a fine stainless steel sieve. Eagle's 
minimum essential medium buffered with 20 mM Hepes (HEM)  was used throughout. The 
cell suspensions were washed three times, the viable cells counted by eosin exclusion, and the 
appropriate number of cells was suspended in 0.2 ml HEM  and injected intravenously into 
naive, syngeneic recipients, which were then challenged within 1 h. 
Treatment with Anti-Thy-l.2 and Complement.  Lymph node cells were prepared from CY and 
KLH-CFA-treated donors as above, washed three times and divided into two equal parts. One 
part  was  incubated  for 30  min  at  4°C  with a  rat  monoclonal anti-Thy-l.2  (gift of Dr.  L. 
Herzenberg)  antibody  purified  from  hybridoma culture  supernatant.  The  other  part  was 
incubated in HEM. All the cells were then washed twice and incubated for 30 min at 37°C 
with rabbit serum absorbed extensively with mouse spleen cells as a  source of complement, 
used at a final dilution of 1:20. The cells were then washed twice and counted. Each recipient 
in both the complement-alone and antibody plus complement groups received 10  7 cells. 
Histology.  In some experiments, sections of ears were stained with hematoxylin and eosin 
after fixation with 10% formalin. 
Results 
Effect of Pertussigen  on DTH in Immunized Mice 
EFFECT  OF  PERTUSSmEn  ON  TrIE  DTH  RESPONSE.  Mice  were  treated  with  400  ng 
pertussigen on the day of immunization with KLH  in CFA and challenged 6 d  later. 
24  h  after  challenge,  a  significantly greater  swelling  was  observed  in  the  ears  of 
pertussigen-treated mice compared with controls (Fig. 1). Over the next few days, the 
ear swelling in the pertussigen-treated mice continued to increase, reaching a  maxi- 
mum 4-7 d after challenge, whereas the control mice returned towards baseline levels. 
In six consecutive experiments similar findings were observed. At 24  h, there was  a 
significant difference in every experiment  (P <  0.02 to <0.001)  between pertussigen- 
treated mice (mean increment in all experiments 282 #m)  and sensitized groups not 
treated with pertussigen  (160 #m).  At 6  or 7 d, the difference was also significant in SEWELL,  MUNOZ, AND VADAS 
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Fxo.  1.  Time  course  of the  effect  of pertussigen  on  DTH  responses.  Groups  of mice  given 
pertussigen  (0,  A)  or  saline  (O,  A)  were  either  immunized  with  KLH-CFA  (0,  O)  or  left 
unimmunized  (A, A). 6 d  later all groups  were challenged with KLH and ear increments were 
measured on the stated days after challenge.  Each point is the arithmetic mean of determinations 
in five mice. Vertical bars span 2 SEM. 
TABLE  I 
Effect of Pertussigen on Nonspecific Inflammatory  Responses * 
Substance  Per-  Incremental footpad thickness after injection 
Group  injected  tussigen  3 d*  6 d  9 d 
~m 
1  Turpentine  +  1,320 ±  119~  1,100  ±  181  657 ±  158 
2  Turpentine  -  1,148 ±  71  857 ±  63  615 ±  190 
3  IFA-saline  +  864 ±  39  790 ±  57  696 ±  43 
4  IFA-saline  -  882 ±  84  874 ±  114  828 ± 83 
2089 
* Mice were injected in the left hind footpad with 20 #1 of turpentine or with 
50/~1 of an emulsion of IFA and saline. Some groups  were given pertussigen 
400 ng i.v. on the same day. 
* Peripheral blood white cell count per mm  3 at 3 d: group 1, 23.4 +  1.9 (x 10  s 
ram-a); group 2, 8.3 +  1.1; group 3, 21.3 ±  1.2; group 4, 9.5 ± 0.9. 
§ Arithmetic mean  ±  1 SEM, 5  mice per group.  The footpad  thickness  in 
untreated mice was 1,798 ± 28/tin. At all time points, there was no significant 
difference in the incremental footpad thickness  between groups  1 and 2 or 
between  groups  3  and  4  (calculated  by  Student's  t  test,  P  >  0.05  not 
significant). 
every experiment  (P <  0.01 to <0.001)  with a  mean increment of 316 #m in pertussigen 
groups and  68/tm  in sensitized controls.  A  significant swelling persisted  for at  least 6 
wk after challenge.  In control  unimmunized  mice treated  with  pertussigen  and  ear- 
challenged with KLH  6  d  later,  there was a  small but significant ear swelling 6-12  d 
after challenge  (Fig.  1).  There  was  little reaction  to  KLH  challenge  in  control  mice 
given CFA, and the small delayed ear swelling seen in pertussigen-treated  nonimmune 
mice did not occur. 
To show that the effect of pertussigen was antigen specific, mice were injected with 
mineral  turpentine  or  with  an  emulsion  of IFA  and  saline.  Since  these  substances 
were  highly  irritating,  the  footpad  was  chosen  as  the  site  of injection.  Pertussigen 
injected  intravenously  on  the same day  had  no  significant  influence on  the  footpad 
swellings at  3,  6, or 9  d  after injection, in spite of the expected pertussigen-mediated 
leukocytosis  (Table  I).  In  contrast,  when  mice  were  injected  in  the  footpad  with 
antigenic  substances  such  as  KLH  in  CFA,  the  footpad  increment  was  doubled  by 
pertussigen at days 6 and 9 (J. J. Munoz  and W. A. Sewell, manuscript  in preparation). 
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or EA in CFA and challenged with KLH, EA, or saline 6 d later. The results in Fig. 
2 show some ear swelling in all groups at 4 h, with no effect of pertussigen. Thereafter 
mice  challenged  with  the  appropriate  antigen  developed  ear  swelling  that  was 
markedly increased by pertussigen. Challenge with the inappropriate antigen without 
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F1o.  2.  Demonstration of the  antigen  specificity of the  pertussigen effect  on  DTH,  Mice  were 
immunized with KLH or EA in CFA, and 6 d  later challenged with KLH, EA, or normal saline 
(NS). Some groups received 400 ng of pertussigen on the day of immunization (open boxes) and other 
groups received  saline  (hatched boxes).  The  ear  increments  are  shown 4  h,  24  h,  and  6  d  after 
challenge. Each value is the arithmetic mean in five mice, and bars represent one SEM above and 
below the mean. 
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FIo.  3.  The effect of the dose of pertussigen on DTH. Varying doses of pertussigen were given to 
groups of mice on the day of immunization  with KLH-CFA  (0). Control  mice  (O) were given 400 
ng of pertussigen on the same day. All groups were challenged 6 d later. Ear increments, measured 
3, 6, and 8  days after challenge,  had similar dose-response curves;  those on day 3 are shown here. 
Each point is the arithmetic mean of measurements  in five mice, and vertical bars span 2 SEM. 
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FIG. 4.  The effect  on DTH of the time of administration of pertussigen. Mice were immunized 
with KLH-CFA at day 0 and given 400 ng pertussigen at various time points (0). Immunized mice 
not given pertussigen are also shown (O). 6 d after immunization, mice were challenged with KLH, 
and the ear increments were measured 4  d  after challenge.  Each point represents the arithmetic 
mean of values in five mice, and the bars span 2 SEM. SEWELL,  MUNOZ, AND VADAS  2091 
pertussigen  did not elicit a  DTH  response.  KLH  challenge in EA-immune  mice was 
not  enhanced  by  pertussigen,  whereas  EA  challenge  in  KLH-immune  mice  was 
slightly increased  by pertussigen.  At  the end  of the experiment,  the inappropriately 
challenged  mice were  challenged  with  the  appropriate  antigen  in  the  opposite  ear, 
and  gave a  strong DTH  reaction. 
EFFECT  OF  DOSE  OF  PERTUSSIGEN ON  DTrL  400  ng  of pertussigen  at  the  time  of 
immunization  with  KLH  in  CFA  produced  a  substantial  increase  in  the  DTH 
response. Lower doses produced a  weaker enhancement,  with a  demonstrable effect at 
doses as low as 25 ng (Fig. 3). 
EFFECT  OF  TIMING  OF  PERTUSSIGEN  ON  DTH.  To  ascertain  the  optimal  time  of 
administration  of pertussigen,  mice were given 400  ng from  21  d  before to  7  d  after 
immunization.  The  mice were challenged  6  d  after immunization  and  ear swellings 
measured  1-28  d  later.  The  results  at  4  d  after  challenge  (Fig.  4)  showed  that 
pertussigen  was most effective given on the day of immunization  or 3  d  later.  Similar 
results  were  seen  at  7  d  after  challenge,  but  from  day  14  to  day  28  mice  given 
pertussigen  3  d  after immunization  had  consistently  higher ear swellings than  mice 
given  pertussigen  on  the  day  of immunization.  For example,  on  day  28  the  values 
were 200  ±  15/xm and  100 ±  19/~m, respectively (P <  0.01). 
INFLUENCE  OF  ADJUVANTS  AND  OF  CY  ON  THE  PERTUSSIGEN  EFFECT.  Mice  were 
immunized  with  EA either  emulsified with  CFA  (Table  II, groups  1-5)  or with  the 
same  quantity  of antigen  in  saline  (groups  6,  7),  and  were  challenged  with  EA 6  d 
later.  Some mice were also pretreated  with CY  (groups 4, 5).  400 ng of pertussigen  or 
heat-inactivated pertussigen was given on the day of immunization  (groups 2, 3, 5, 7). 
Pertussigen  increased  DTH  to soluble EA or EA-CFA, with or without  CY, 24 h  and 
even more markedly 6  d  after challenge. To investigate the role of lipopolysaccharide 
in these observations,  the pertussigen  preparation  was heated  for 20 min in a  boiling 
TABLE  II 
Effect of Pertussigen and CY on DTH to EA 
Group  CY* 
Pertussigen 
EA*  on day of im- 
munization  § 
Incremental ear thickness  after challenge 
24 h  pI  6 d  P 
ng  wn 
1  -  CFA  0  154 ±  231  64 ±  8 
2  --  CFA  400  280 ±  2  <0.01  364 +  39  <0.001 
3  -  CFA  400 H**  160 ±  2  NS  88 ±  29  NS 
4  +  CFA  0  212 ±  7  112 ±  11 
5  +  CFA  400  286 ±  12  <0.001  390 ±  36  <0.001 
6  -  PBS  0  116 ±  19  90 ±  24 
7  -  PBS  400  172 ±  13  <0.05  236 ±  9  <0.001 
8  Challenge only (nonimmune)  84 ±  23  42 ±  5 
* 100 mg/kg CY was given to some groups  (+) 2 d before immunization. 
50/~g of EA was given in either CFA or in PBS, subcutaneously. 
§ Pertussigen  (400 ng) on the day of challenge enhanced DTH 6 d after challenge, but was 
ineffective at 24 h. 
** Heat-inactivated pertussigen  was  heated  in  a  boiling water bath  for 20  min.  Heated 
pertussigen  given to mice treated with CY and EA-CFA was also ineffective. 
~1 Arithmetic mean +  1 SEM. There were five mice per group. 
I p  values are estimated by Student's t test.  In groups 2 and 3, values are calculated by 
comparison with group 1; in group 5 with group 4; and in group 7 with group 6. NS, not 
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water bath, a  treatment  known to inactivate pertussigen  but not lipopolysaccharide. 
The heat-treated  material  was ineffective in this system  (Table  II). In addition,  400 
ng of B. pertussis lipopolysaecharide  had  no effect  on  DTH  (data  not  shown).  Also 
notable was that CY, another agent that increases DTH, only had a marked influence 
at 24 h  and, unlike pertussigen, CY was much less effective at 6 d. There was little or 
no additive effect when both CY and pertussigen were given. 
HISTOLOOV.  Histologic examination  demonstrated  that  there was no appreciable 
cellular infiltrate  in ears taken 4  h  after challenge, whereas a  mononuclear infiltrate 
was present  in immune  mice at  24 h, with  and without  pertussigen.  In the immune 
mice not treated  with  pertussigen,  the cellular  infiltrate  waned  by 6  d, whereas  the 
infiltrate in the pertussigen-treated  mice persisted and was still predominantly mono- 
nuclear  (Fig. 5). 
Effect of Pertussigen on Passive Transfer of DTH.  To examine the effect of pertussigen 
on the recipients of sensitized cells, lymph node cells from CY-pretreated KLH-CFA- 
immunized  mice  were  injected  into  nonimmune  syngeneic  recipients  that  were 
immediately  ear challenged  with  KLH.  These  recipients  developed  an ear swelling 
that was maximal at  24 h  and waned thereafter  (Table  III). It should be noted that 
ear  swellings  declined  more  slowly  in  the  recipients  of sensitized  cells  than  in  the 
immunized mice themselves.  When pertussigen was given to recipients at the time of 
transfer, there was a small decrease in the 24 h reaction in some experiments. However, 
pertussigen significantly increased the swelling at later time points  (Table III, exper- 
iment  1). The administration of pertussigen to donor mice increased the efficiency of 
cell  transfer  at  24 h  but  the reactions did not increase  thereafter  (experiment  2).  In 
mice that did not receive cells, ear injection of KLH caused a small swelling that was 
not  affected  by  pertussigen  for  the  first  4  d,  but  increased  slightly  in  the  later 
F1o. 5.  Histologic  appearance  of ear sections stained with hematoxylin and eosin. ×  150. Mice 
were immunized with KLH-CFA and challenged with KLH 6 d later. The ears were taken 6 d after 
challenge. (Left)  400 ng pertussigen was given on the day of immunization. (Right) No pertussigen 
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Influence of Pertussigen and Cydophosphamide on the Passive Transfer of D TH to KLH * 
2093 
Experi- 
ment 
Donors  Recipi-  Cell num- 
ents  ber trans- 
ferred 
CY  P  P 
Ear increment (~m) after challenge* 
Day 1  Day 4  Day 6  Day 11 
+  -  +  15×  106  190±  10  ++  393±25 +  553±54 +  258±36 ++ 
+  -  -  15 X  106  240 +  7  223 ±  7  205 ±  20  118 +  7 
-  -  +  Nil  43±  10  60±  14  93±  11  90±8 
-  --  --  Nil  75±7  40±8  55±  15  40±7 
Day 1  Day 2  Day 4 
i 
10 X  106  196 ±  12  +  215 ±  12  +  192  ±  17 ++ 
10×  106  114±4  96±8  96±  14 
Nil  48 ±  2  33 ±  6  25 +  3 
-  + 
* Donor mice were sensitized with KLH-CFA and treated with or without pertussigen (P)  (400 ng on the 
day of immunization) or CY  (150  mg/kg 2 d  before immunization). Recipients  in some groups were 
treated with pertussigen (400  ng on the day of transfer). 5 d  after immunization, the stated number of 
lymph node cells was transferred. Ear thickness was measured on the stated days after challenge. 
*Arithmetic mean ±  1 SEM, four to five mice per group. P values are determined by comparison of groups 
in which donors or recipients of sensitized cells  received pertussigen with control groups which received 
sensitized cells. +, <0.001;  ++, <0.01. 
TABLE  IV 
Effect of Anti-Thy-l.2 Antibody and Complement on the Transfer of DTH into 
Normal and Pertussigen-treated Recipients 
Incremental ear thickness*  after challenge in 
recipients given: 
Treatment of donor 
cells *  Pertussigen  Saline 
24h  6d  24h  6d 
~m 
Anti-Thy-l.2 and  37 ±  25  83 ±  9  47 ±  22  37 ±  21 
complement 
Complement alone  177 +  15  333 ±  9  155 ±  46  125 ±  16 
No cells  45:1:7  84 ±  25  32 ±  4  15 ±  4 
* Lymph node cells from mice treated with CY and KLH-CFA were incubated with 
complement  and  antibody  or complement  alone  as  described  in  Materials  and 
Methods.  Recipients  were  treated  with  400  ng pertussigen or  saline  6  d  before 
transfer. 
* Arithmtetic mean ±  1 SEM, with three to six mice per group, 
measurements (experiment 1). The passive transfer into normal or pertussigen-treated 
recipients was characteristic of DTH in being abolished by monoclonal anti-Thy-1.2 
and complement (Table IV). 
Discussion 
B. pertussis vaccine and impure extracts of the lymphocytosis-promoting factor of B. 
pertussis have previously been shown to have either facilitatory or inhibitory effects on 2094  INDUCTION  OF DELAYED-TYPE HYPERSENSITIVITY BY PERTUSSIGEN 
DTH  (10,  13).  In this paper we show that  pertussigen,  a  purified protein from B. 
pertussis,  has several remarkable facilitatory effects on DTH in mice. First, it enhanced 
approximately twofold the magnitude of DTH measured 24 h  after challenge (Fig. 
1). Second, the peak intensity of DTH was changed from the normal  1-2 d to 4-7 d 
after  challenge  (Figs.  1,  2)  at  which  time  an  approximately  fivefold increase  in 
intensity  was  evident.  Third,  DTH  reactions  with  pertussigen  persisted  so  that 
detectable ear swelling was present for at least 3 wk (Fig.  1) to as much as 6 wk (data 
not shown) after ear challenge, in comparison with control mice where it declined to 
near background levels by 6-7  d  (Figs.  1,  2).  It should be noted that  the effect of 
pertussigen was unlike that of CY, another agent used for enhancing DTH. Although 
CY increased DTH at 24 h, these reactions declined thereafter (Table II), suggesting 
that  these  two  agents  have a  dissimilar  mechanism  of action.  In  spite  of this  the 
pertussigen-promoted reactions had the characteristics of DTH, with a delayed onset 
(Fig.  2),  antigen  specificity (Fig.  2),  H-2  restriction  (data  not  shown), and  typical 
histology (Fig. 5). Furthermore, inflammatory responses to irritant agents, not known 
to be antigenic, were not markedly enhanced by pertussigen, suggesting that its effect 
was primarily on antigen-driven inflammatory responses. 
Besides the effect on immunized mice, pertussigen also caused a delayed increase in 
the intensity of DTH, when given to the recipients of sensitized cells.  It was notable 
that  no increase was evident in the recipients 24 h  after ear challenge (Table III), 
suggesting that an immune reaction and the effects mediated by pertussigen had to 
coexist for a critical period for enhancement of DTH to be seen. T  cells were at least 
in part responsible for this reaction as it was abolished by treatment of lymph node 
cells  with  anti-Thy-l.2  serum  and  complement  (Table  IV). In  contrast  to  the 
treatment  of recipients, pertussigen  treatment of donor-sensitized cells did increase 
the magnitude of the 24-h ear reaction. However, this reaction did not increase on 
subsequent days (Table III). These findings suggest that the adjuvant-like effects of 
pertussigen on sensitized lymph node cells did not account for the delayed peak of 
intensity that occurred in pertussigen-treated recipients. 
The pertussigen  used  in our experiments was  purified to crystallization but  it  is 
possible  that  traces  of contaminating  substances  could  account  for the  biological 
activities. However, the most likely contaminant, endotoxin, had no significant effect 
on DTH (data not shown), making its role in this unlikely. Furthermore, the activity 
on DTH was destroyed by heating the preparation in a boiling water bath for 20 min 
(Table II), a treatment known to destroy other biological activities of pertussigen (10). 
Pertussigen has several other biological effects, notably, induction of lymphocytosis 
with  inhibition  of lymphocyte homing  to  lymphoid  organs  (14),  sensitization  to 
histamine, enhancement of production of IgE, and increased incidence and severity 
of experimental autoimmune encephalomyelitis (15). The relationship of the mecha- 
nisms  involved  in  pertussigen's  effects on  DTH  to  those  of its  other  functions  is 
currently  under  investigation,  but  the  narrow  time  frame  in  which  it  exerts  its 
maximal effect on DTH  (Fig.  4)  makes it unlikely that  the phenomenon is totally 
explicable by its histamine-sensitizing property insofar as the latter has an extremely 
protracted time course  (10).  The lymphocytosis-promoting effect, which  peaks  3  d 
after the  administration  of pertussigen,  may well  be associated  with  the  effect on 
DTH. Furthermore, an increased number of mast cell precursors have been observed 
in pertussigen-treated mice (R. M. Crapper, W. A. Sewell, J. W. Schrader, and M. A. SEWELL, MUNOZ, AND VADAS  2095 
Vadas, unpublished observations), suggesting that they may play a role in regulating 
the persistence as well as the development (16) of DTH. 
At this stage, even without knowledge of the precise mode of action, we believe that 
pertussigen has great potential for enhancing the detection of sensitization by poor 
immunogens, e.g., soluble EA (Table II) and antiidiotypic sera  (17).  In addition it 
provides a  model of prolonged T  cell-dependent reactions that may lead to a  better 
understanding of the regulation of chronic inflammation. 
Summary 
Pertussigen,  a  purified  protein  from  Bordetdla  pertussis,  was  shown  to  increase 
delayed-type hypersensitivity (DTH)  to protein antigens in mice. First, it caused an 
approximately  twofold  enhancement  of  the  magnitude  of  24-h  DTH  reactions. 
Second, the peak magnitude of DTH was delayed to 4-7 d after challenge, at which 
time  it  was  five  times  more  intense  than  in  mice  not  receiving  pertussigen.  This 
reaction was antigen specific, and histologically was characterized by a  dense mono- 
nuclear infiltrate.  Third, pertussigen prolonged DTH so that  it was still  detectable 
3-6  wk after  challenge.  The  effect  of pertussigen  was  seen  only in  antigen-driven 
reactions and was time and dose dependent, with 400 ng given 3 d after immunization 
resulting  in  the  most prolonged reaction.  The administration  of pertussigen  to the 
recipients of sensitized lymph node cells resulted in DTH that was more intense and 
prolonged than the reactions in control mice. Administration of pertussigen provides 
a model of prolonged and enhanced T  cell-dependent inflammatory responses. 
We  thank  Dr.  I.  R.  Mackay for critical  review of the  manuscript,  and J.  R.  Gamble for 
providing complement. 
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